Skip to content
Psilocybin Research
Menu
    Primary NavigationPrimary Navigation
    • Home
    • Psilocybin Facts
      • History
        • Albert Hofmann
      • Ongoing/recently completed clinical trials
      • Latest scientific publications
      • Legals aspects concerning psilocybin
      • Molecular Structure & Chemical Details
    • Neuroscience
      • Psilocybin as a partial agonist of the 5-HT2A receptor
      • Neuronal interconnectivity
      • Neurochemical correlates of creativity
      • Psilocybin and neuroplasticity
      • Neuropolitics
      • Mycelia networks, adaptogens, and mental health
      • Neurochemistry
    • Psychology
      • Cross-modal synesthesia
      • Psilocybin and creativity
      • Psilocybin and ego-dissolution
      • Psilocybin and metacognition
      • Psilocybin and shamanism
      • Psilocybin and near-death anxiety
      • Psilocybin as a therapeutic adjunct for PTSD
      • Psilocybin and visual perception
      • Psilocybin as a catalyst of spiritual experiences
    • Psilocybin & Genetic Ageing
    • Philosophy of Mind
      • Psilocybin and Qualia
    • Misc
          • Imaginal cells
          • Full reference list HTML
          • From psychotomimetic to psychedelic
          • GoogleTrends analysis for Psilocybin (R-code)
          • Page overview
          • Media coverage of psilocybin
          • Hologenome theory of evolution
          • Documentaries
          • News
          • Podcasts
          • Psilocybin Research Blog
          • CogNovo
          • John M. Allegro
          • MindMap (dynamic information visualization)
          • Lectures
          • Homo consumens
          • Philosophy
          • Paul H. Hoch – Experimental lobotomies and psychopathology
          • Chemistry
          • Marie-Curie actions
          • CIA project MK Ultra
          • Gordon Wasson
          • A Review of the Clinical Effects of Psychotomimetic Agents
          • Mycophilia
          • EU FP7
          • Newsletter
          • www.psychedelic-lab.com
    • Varia
      • RSS

Tag: Epidemiology

Annecdotal evidence / Empirical studies / Misc

Psilocybin & Mental Health

Elsey, J. W. B. (2017). Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy. Drug Science, Policy and Law, 3, 205032451772323. Argento, E., …

psilocybin-research-logo-250px

Psilocybin-Research.com

Machine Learning Powered AI Translation

en English
af Afrikaansar العربيةbn বাংলাbg Българскиzh-CN 简体中文hr Hrvatskics Čeština‎da Dansknl Nederlandsen Englishtl Filipinofi Suomifr Françaisde Deutschel Ελληνικάgu ગુજરાતીiw עִבְרִיתhi हिन्दीit Italianoja 日本語ko 한국어lv Latviešu valodaml മലയാളംne नेपालीno Norsk bokmålfa فارسیpl Polskipt Portuguêsru Русскийsl Slovenščinaes Españolsv Svenskata தமிழ்th ไทยtr Türkçeur اردوzu Zulu

Search Function

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Anything in here will be replaced on browsers that support the canvas element
  • Ego-dissolution
  • Psilocybin
  • Neurogenesis
  • Creativity
  • Ego-death
  • Psilocybin Patents
  • Psilocybin Innovations
  • Synaptoplasticity
  • Schizophrenia
  • Shamanism
  • Albert Hofmann
  • Hippocampus
  • 5-HT2A receptor
  • Neuroplasticity
  • Epidemiology
  • Suicidality
  • Mental Health
  • Openness to Experience
  • 5-Factor Model
  • Personality
  • Clinical Trials
  • Experimental Studies

Recent Posts

  • References 2022
  • Kary B. Mullis “Getting down with the molecules”
  • Psilocybin & Mental Health

Categories

Links

  • http://epigenetic-programming.de/
  • http://entheogen-science.de/
  • http://belief-bias.de/
  • http://self-reflection.de/
  • https://cognitive-liberty.online/
  • https://cognovo.net/
  • https://qbism.art/
  • https://psilocybin-research.com/

Search Function

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Tags

5-Factor Model5-HT2A receptorAlbert HofmannCreativityEgo-deathEgo-dissolutionEpidemiologyHippocampusMental HealthNeurogenesisNeuroplasticityOpenness to ExperiencePersonalityPsilocybinPsilocybin InnovationsPsilocybin PatentsSchizophreniaShamanismSuicidalitySynaptoplasticity

Links
http://entheogen-science.de

Categories

  • Annecdotal evidence
  • Empirical studies
  • General
  • Media reports
  • Misc

Translation

en English
af Afrikaansar العربيةbn বাংলাbg Българскиzh-CN 简体中文hr Hrvatskics Čeština‎da Dansknl Nederlandsen Englishtl Filipinofi Suomifr Françaisde Deutschel Ελληνικάgu ગુજરાતીiw עִבְרִיתhi हिन्दीit Italianoja 日本語ko 한국어lv Latviešu valodaml മലയാളംne नेपालीno Norsk bokmålfa فارسیpl Polskipt Portuguêsru Русскийsl Slovenščinaes Españolsv Svenskata தமிழ்th ไทยtr Türkçeur اردوzu Zulu

Psilocybin Newsletter

Quotation

When we look within ourselves with psilocybin, we discover that we do not have to look outward toward the futile promise of life that circles distant stars in order to still our cosmic loneliness. We should look within; the paths of the heart lead to nearby universes full of life and affection for humanity.Terrence McKenna (*1946;†2000)
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
(CC) 2016— by Dr. Christopher B. Germann (PhD, MSc, BSc, Marie Curie Alumnus)
https://neuropsy-webdesign.de
The project www.Psilocybin-Research.com was funded by the EU Marie Curie Initial Training Network FP7-PEOPLE-2013-ITN-604764
→ Primary goals of research and innovation policy as defined by the European Comission: Open Innovation, Open Science, Open to the World.
https://www.cognovo.eu/people/research-fellows/christopher-germann.php

Legal disclaimer: The interdisciplinary Marie Curie CogNovo program has been intentionally designed by the European Union and the University of Plymouth (United Kingdom) to discuss and disseminate a wide view on a diverse spectrum of topics including psychology, neuroscience, current affairs, basic science, humanities, and the arts, inter alia. Note that the views and opinions expressed on this website do not necessarily represent the opinions of any of the institutions mentioned on this website and belong exclusively to the copyright holder. The CogNovo program explicitly emphasises cognitive and social innovation, the generation of new ideas and perspectives, and the probing of boundaries, but see https://www.cognovo.eu/about/
Copyright © 2023 Psilocybin Research – OnePress theme by FameThemes